These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1920351

  • 21. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK, Hietala J, Röyttä M, Grönroos J.
    Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
    [Abstract] [Full Text] [Related]

  • 22. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW, Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [Abstract] [Full Text] [Related]

  • 23. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR, Wolfe BB.
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [Abstract] [Full Text] [Related]

  • 24. Properties and distribution of muscarinic cholinergic receptors in rat striatal micropunched tissue homogenates.
    Takano Y, Uchimura K, Kohjimoto Y, Kamiya H.
    Eur J Pharmacol; 1981 Apr 09; 70(4):559-64. PubMed ID: 7238577
    [Abstract] [Full Text] [Related]

  • 25. A comparison of the distribution of acetylcholinesterase and muscarinic cholinergic receptors in the feline neostriatum.
    Brand S.
    Neurosci Lett; 1980 Apr 09; 17(1-2):113-7. PubMed ID: 7052452
    [Abstract] [Full Text] [Related]

  • 26. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW, Binder HJ.
    Gastroenterology; 1982 Dec 09; 83(6):1244-51. PubMed ID: 6127277
    [Abstract] [Full Text] [Related]

  • 27. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
    Waelbroeck M, Tastenoy M, Camus J, Christophe J.
    Mol Pharmacol; 1991 Sep 09; 40(3):413-20. PubMed ID: 1896027
    [Abstract] [Full Text] [Related]

  • 28. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T, Tsukahara T, Fujiwara M.
    Life Sci; 1983 Apr 11; 32(15):1757-63. PubMed ID: 6835022
    [Abstract] [Full Text] [Related]

  • 29. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE, Eckelman WC, Vieras F, Reba RC.
    J Nucl Med; 1979 Aug 11; 20(8):865-70. PubMed ID: 541735
    [Abstract] [Full Text] [Related]

  • 30. Muscarinic cholinergic receptors in developing rat lung.
    Whitsett JA, Hollinger B.
    Pediatr Res; 1984 Nov 11; 18(11):1136-40. PubMed ID: 6514439
    [Abstract] [Full Text] [Related]

  • 31. Repeated noise exposure affects muscarinic cholinergic receptors in the rat brain.
    Lai H, Carino MA, Wen YF.
    Brain Res; 1989 May 29; 488(1-2):361-4. PubMed ID: 2743133
    [Abstract] [Full Text] [Related]

  • 32. Aged Stone maze-impaired rats exhibit reduced striatal muscarinic receptor densities.
    Bratt AM, Kelly ME, Domeney AM, Naylor RJ, Costall B.
    Neuroreport; 1994 Dec 20; 5(18):2678-82. PubMed ID: 7696631
    [Abstract] [Full Text] [Related]

  • 33. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
    Hruska RE, Ludmer LM, Pert A, Bunney WE.
    J Neurosci Res; 1984 Dec 20; 11(2):171-7. PubMed ID: 6423831
    [Abstract] [Full Text] [Related]

  • 34. Orthovanadate induces loss of muscarinic cholinergic binding sites.
    Danielsson E, Undén A, Bartfai T.
    Biochem Biophys Res Commun; 1983 Jan 27; 110(2):567-72. PubMed ID: 6551164
    [Abstract] [Full Text] [Related]

  • 35. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 27; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 36. Phenylclindine-induced alteration in rat muscarinic cholinergic receptor regulation.
    Ward D, Trevor A.
    Eur J Pharmacol; 1981 Sep 11; 74(2-3):189-93. PubMed ID: 7327201
    [Abstract] [Full Text] [Related]

  • 37. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI.
    J Pharmacol Exp Ther; 1987 Jan 11; 240(1):51-8. PubMed ID: 3806397
    [Abstract] [Full Text] [Related]

  • 38. Cholinergic muscarinic receptors in rat cochlea.
    van Megen YJ, Klaassen AB, Rodrigues de Miranda JF, Kuijpers W.
    Brain Res; 1988 Nov 22; 474(1):185-8. PubMed ID: 3214711
    [Abstract] [Full Text] [Related]

  • 39. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B, Jaszczak R, Coleman E, Storni A, Greer K, Petry N, Lischko M, Flanagan S.
    J Comput Assist Tomogr; 1982 Jun 22; 6(3):536-43. PubMed ID: 6980235
    [Abstract] [Full Text] [Related]

  • 40. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA, van Vugt MA, de Boer T, de Graaf JS.
    Life Sci; 1987 May 18; 40(20):1981-7. PubMed ID: 3573989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.